Study Summary
This trial is testing a new drug to see if it can stop or slow the growth of vision loss from GA due to AMD. It will last about 19 months.
- Age-Related Macular Degeneration (AMD)
Treatment Effectiveness
Study Objectives
1 Primary · 4 Secondary · Reporting Duration: Baseline to Month 18
Trial Safety
Trial Design
4 Treatment Groups
ANX007 Group 1
1 of 4
ANX007 Group 2
1 of 4
Sham Group 3
1 of 4
Sham Group 4
1 of 4
Experimental Treatment
Non-Treatment Group
270 Total Participants · 4 Treatment Groups
Primary Treatment: ANX007 · Has Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Florida | 57.1% |
| Texas | 14.3% |
| Nevada | 14.3% |
| Other | 14.3% |
How old are they?
| 65+ | 66.7% |
| 18 - 65 | 33.3% |
What site did they apply to?
| Site 6 | 25.0% |
| Site 4 | 25.0% |
| Site 11 | 25.0% |
| Other | 25.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 71.4% |
| Did not meet criteria | 28.6% |
Why did patients apply to this trial?
- "I am anxious to preserve the vision I have left."
- "I am trying everything possible to halt the progression of my condition if not improve it. On the first page there was a Jacksonville. FL location but it did not appear on the list of potions to select."
How many prior treatments have patients received?
| 3+ | 100.0% |
What questions have other patients asked about this trial?
- "When would it start?"
Frequently Asked Questions
Does ANX007 present any safety risks to individuals?
"Our team has assigned ANX007 a safety rating of 2, given that there is some substantiating evidence to suggest its protection but no studies yet confirming it's usefulness." - Anonymous Online Contributor
Has recruitment begun for this experimental research initiative?
"Clinicaltrials.gov states that this trial, initially posted on February 26th 2021 and last updated July 1st 2022, is not actively searching for participants. However, there are 189 other promising studies currently recruiting volunteers." - Anonymous Online Contributor
What is the scale of this clinical trial across medical facilities?
"Apart from the three previously mentioned sites, participants for this trial can be found in Site 35 Katy, Texas; Site 34 Burleson, California and Site 23 Pasadena, Florida. Additionally there are 46 other enrolment locations." - Anonymous Online Contributor